Enveric Biosciences (STU:SLZ0) Institutional Ownership: 1.27% (As of Aug. 11, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:SLZ0 Enveric Biosciences Inc STU:SLZ0
31 GF Score
Price €55.89
! 1 Warning Sign
View Full Analysis

What is Enveric Biosciences Institutional Ownership?

Enveric Biosciences STU:SLZ0 31 Institutional Ownership is 1.27% as of Aug. 11, 2026. GuruFocus rates STU:SLZ0 with a GF Score™ of 31/100. The stock has 1 warning sign investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Enveric Biosciences's institutional ownership is 1.27%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Enveric Biosciences's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Enveric Biosciences's Float Percentage Of Total Shares Outstanding is 98.83%.

Enveric Biosciences Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Enveric Biosciences's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enveric Biosciences Institutional Ownership Chart

Enveric Biosciences Historical Data

The historical data trend for Enveric Biosciences can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 34.25 34.26 2.09 1.59 2.40 4.67 5.01 4.23 1.20 1.27
STU:SLZ0
31GF Score
Enveric Biosciences Inc STU:SLZ0
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Enveric Biosciences Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 1.27% mean?
Enveric Biosciences (STU:SLZ0) has a Institutional Ownership of 1.27% as of Aug. 11, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Enveric Biosciences and its competitors.
Is Enveric Biosciences' Institutional Ownership too high?
Enveric Biosciences' current Institutional Ownership is 1.27%. Overall, Enveric Biosciences has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Enveric Biosciences' Institutional Ownership compare to ALZN and SILO?
Enveric Biosciences' Institutional Ownership of 1.27% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Enveric Biosciences and its competitors. Enveric Biosciences's current Institutional Ownership is 1.27%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enveric Biosciences stock overvalued right now?
Enveric Biosciences (STU:SLZ0) has a current Institutional Ownership of 1.27%. The current Institutional Ownership is 1.27%. Enveric Biosciences' overall GF Score™ is 31/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Enveric Biosciences (STU:SLZ0), the current Institutional Ownership is 1.27% as of Aug. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Enveric Biosciences Business Description

Other Exchanges ENVB:USA
Address 245 First Street, 18th Floor, Riverview II, Cambridge, MA, USA, 02142
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
31GF Score

Get the complete analysis for STU:SLZ0

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€55.89
Price